FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.

Informacje na temat projektu

FibroFix

Identyfikator umowy o grant: 854646

DOI

10.3030/854646

Projekt został zamknięty

Data podpisania przez KE 11 Kwietnia 2019

Data rozpoczęcia 1 Stycznia 2019

Data zakończenia 30 Kwietnia 2019

Finansowanie w ramach

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Koszt całkowity

€ 71 429,00

Wkład UE

€ 50 000,00

Koordynowany przez

ORTHOX LIMITED
United Kingdom

Periodic Reporting for period 1 - FibroFix (FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.)

Okres sprawozdawczy: 2019-01-01 do 2019-04-30

Podsumowanie kontekstu i ogólnych celów projektu

Cartilage deterioration and injuries often lead to osteoarthritis (OA) – a long-term chronic disease resulting in bones rubbing together and creating pain, stiffness and severe disability. Knee cartilage injuries are very common and almost half of them go on to develop OA, which is second only to heart disease as a cause of work disability. Orthox has developed and plans to bring to market FibroFix Cartilage - a product developed to treat damage to the articular cartilage in the knee, including degeneration and OA.

Prace wykonane od początku projektu do końca okresu sprawozdawczego oraz najważniejsze dotychczasowe rezultaty

During the feasibility assessment, Orthox has completed a full analysis of the technical and business potential of their FibroFix Cartilage. Throughout the project, Orthox has greatly expanded their knowledge regarding the clinical validation and regulatyory approval required for the European market launch. Orthox also identified all key stakeholders needed for commercialisation.

Innowacyjność oraz oczekiwany potencjalny wpływ (w tym dotychczasowe znaczenie społeczno-gospodarcze i szersze implikacje społeczne projektu)

To prevent total knee replacement, many patients who suffer injury to the meniscus or knee cartilage are advised to limit their activity or risk deterioration of the joint. Orthox offers an alternative - strong, resilient, natural implants capable of restoring knee function while allowing the body’s own cells to grow through and integrate with the device. It is expected that this solution will allow patients to return to a fully active, pain-free lifestyle.

silk-cocoon-orthox.jpg

fibrofix-cartilage-orthox.jpg